FDA commissioner-nominee Marty Makary pledges during his confirmation hearing to do an “independent assessment on personnel” before recommending if any additional staff cuts are warranted at the agency.
FDA denies a hearing on Vanda’s Hetlioz sNDA and proceeds with its rejection of the filing.
FDA commissioner-nominee Marty Makary pledges during his confirmation hearing to do an “independent assessment on personnel” before recommending if any additional staff cuts are warranted at the agency.
FDA denies a hearing on Vanda’s Hetlioz sNDA and proceeds with its rejection of the filing.
FDA reports on a 2024 workshop on using dynamic tools to enhance new drug development efficiency.
Medtronic’s Micro Therapeutics unit recalls its Pipeline Vantage Embolization Device with Shield Technology after it determined that the use of the embolization device may lead to incomplete wall apposition and braid deformation.
